arrow
O

Ola M. Saad

Genentech Inc.
H指数:27
被引数:3,948

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration

Polatuzumab vedotin在CNS淋巴瘤中的应用:关于血脑屏障穿透的可行性研究

2025-10-100
OAAI
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results
2024-01-119
OAAI
Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1

缺氧通过磷酸化Caveolin-1的重新分布减弱曲妥珠单抗的摄取和曲妥珠单抗-T-DM1 (Emtansine) 的细胞毒性

2020-04-0221
OAAI
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers
2019-06-0179
OAAI
Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo
2019-04-1016
PREAI
Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemia
MABS
IF7.3
2018-10-0213
OAAI